779 related articles for article (PubMed ID: 21965298)
41. R521C and R521H mutations in FUS result in weak binding with Karyopherinβ2 leading to Amyotrophic lateral sclerosis: a molecular docking and dynamics study.
Swetha RG; Ramaiah S; Anbarasu A
J Biomol Struct Dyn; 2017 Aug; 35(10):2169-2185. PubMed ID: 27381509
[TBL] [Abstract][Full Text] [Related]
42. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation.
Sama RR; Fallini C; Gatto R; McKeon JE; Song Y; Rotunno MS; Penaranda S; Abdurakhmanov I; Landers JE; Morfini G; Brady ST; Bosco DA
Sci Rep; 2017 Mar; 7(1):115. PubMed ID: 28273913
[TBL] [Abstract][Full Text] [Related]
43. Subcellular localization and RNAs determine FUS architecture in different cellular compartments.
Yang L; Zhang J; Kamelgarn M; Niu C; Gal J; Gong W; Zhu H
Hum Mol Genet; 2015 Sep; 24(18):5174-83. PubMed ID: 26123490
[TBL] [Abstract][Full Text] [Related]
44. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
[TBL] [Abstract][Full Text] [Related]
45. FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription.
Yamaguchi A; Takanashi K
Sci Rep; 2016 Oct; 6():35195. PubMed ID: 27731383
[TBL] [Abstract][Full Text] [Related]
46. The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.
Liu X; Chen J; Liu W; Li X; Chen Q; Liu T; Gao S; Deng M
Neurogenetics; 2015 Jul; 16(3):223-31. PubMed ID: 25912081
[TBL] [Abstract][Full Text] [Related]
47. A yeast model of FUS/TLS-dependent cytotoxicity.
Ju S; Tardiff DF; Han H; Divya K; Zhong Q; Maquat LE; Bosco DA; Hayward LJ; Brown RH; Lindquist S; Ringe D; Petsko GA
PLoS Biol; 2011 Apr; 9(4):e1001052. PubMed ID: 21541368
[TBL] [Abstract][Full Text] [Related]
48. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS.
Ito D; Seki M; Tsunoda Y; Uchiyama H; Suzuki N
Ann Neurol; 2011 Jan; 69(1):152-62. PubMed ID: 21280085
[TBL] [Abstract][Full Text] [Related]
49. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice.
Shelkovnikova TA; Peters OM; Deykin AV; Connor-Robson N; Robinson H; Ustyugov AA; Bachurin SO; Ermolkevich TG; Goldman IL; Sadchikova ER; Kovrazhkina EA; Skvortsova VI; Ling SC; Da Cruz S; Parone PA; Buchman VL; Ninkina NN
J Biol Chem; 2013 Aug; 288(35):25266-25274. PubMed ID: 23867462
[TBL] [Abstract][Full Text] [Related]
50. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.
Lagier-Tourenne C; Polymenidou M; Hutt KR; Vu AQ; Baughn M; Huelga SC; Clutario KM; Ling SC; Liang TY; Mazur C; Wancewicz E; Kim AS; Watt A; Freier S; Hicks GG; Donohue JP; Shiue L; Bennett CF; Ravits J; Cleveland DW; Yeo GW
Nat Neurosci; 2012 Nov; 15(11):1488-97. PubMed ID: 23023293
[TBL] [Abstract][Full Text] [Related]
51. Nucleo-cytoplasmic shuttling of protein arginine methyltransferase 1 (PRMT1) requires enzymatic activity.
Herrmann F; Fackelmayer FO
Genes Cells; 2009 Mar; 14(3):309-17. PubMed ID: 19170758
[TBL] [Abstract][Full Text] [Related]
52. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.
Bosco DA; Lemay N; Ko HK; Zhou H; Burke C; Kwiatkowski TJ; Sapp P; McKenna-Yasek D; Brown RH; Hayward LJ
Hum Mol Genet; 2010 Nov; 19(21):4160-75. PubMed ID: 20699327
[TBL] [Abstract][Full Text] [Related]
53. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
Ito D; Suzuki N
Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
[TBL] [Abstract][Full Text] [Related]
54. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
[TBL] [Abstract][Full Text] [Related]
55. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.
Kamelgarn M; Chen J; Kuang L; Arenas A; Zhai J; Zhu H; Gal J
Biochim Biophys Acta; 2016 Oct; 1862(10):2004-14. PubMed ID: 27460707
[TBL] [Abstract][Full Text] [Related]
56. Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics.
Baron DM; Kaushansky LJ; Ward CL; Sama RR; Chian RJ; Boggio KJ; Quaresma AJ; Nickerson JA; Bosco DA
Mol Neurodegener; 2013 Aug; 8():30. PubMed ID: 24090136
[TBL] [Abstract][Full Text] [Related]
57. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles.
An H; Skelt L; Notaro A; Highley JR; Fox AH; La Bella V; Buchman VL; Shelkovnikova TA
Acta Neuropathol Commun; 2019 Jan; 7(1):7. PubMed ID: 30642400
[TBL] [Abstract][Full Text] [Related]
58. Genome wide array analysis indicates that an amyotrophic lateral sclerosis mutation of FUS causes an early increase of CAMK2N2 in vitro.
Convertini P; Zhang J; de la Grange P; Hayward LJ; Zhu H; Stamm S
Biochim Biophys Acta; 2013 Aug; 1832(8):1129-35. PubMed ID: 23545117
[TBL] [Abstract][Full Text] [Related]
59. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish.
Yu Y; Chi B; Xia W; Gangopadhyay J; Yamazaki T; Winkelbauer-Hurt ME; Yin S; Eliasse Y; Adams E; Shaw CE; Reed R
Nucleic Acids Res; 2015 Mar; 43(6):3208-18. PubMed ID: 25735748
[TBL] [Abstract][Full Text] [Related]
60. The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for
Tischbein M; Baron DM; Lin YC; Gall KV; Landers JE; Fallini C; Bosco DA
J Biol Chem; 2019 Jun; 294(26):10194-10210. PubMed ID: 31092554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
